| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Jiangsu Chinagreen Biological Technology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.69 |
| 52 Week High | CN¥28.70 |
| 52 Week Low | CN¥9.27 |
| Beta | 0.72 |
| 1 Month Change | -16.44% |
| 3 Month Change | -25.11% |
| 1 Year Change | -55.47% |
| 3 Year Change | -61.83% |
| 5 Year Change | n/a |
| Change since IPO | -72.13% |
Recent News & Updates
Shareholder Returns
| 300970 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -10.1% | 0.5% | -0.4% |
| 1Y | -55.5% | -21.2% | -16.2% |
Return vs Industry: 300970 underperformed the CN Food industry which returned -21.5% over the past year.
Return vs Market: 300970 underperformed the CN Market which returned -17.6% over the past year.
Price Volatility
| 300970 volatility | |
|---|---|
| 300970 Average Weekly Movement | 10.4% |
| Food Industry Average Movement | 7.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 300970's share price has been volatile over the past 3 months.
Volatility Over Time: 300970's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 2,197 | Yangchao Yu | www.hualvbio.com |
Jiangsu Hualv Biological Technology Co.,Ltd. engages in the research, development, production, and sale of edible fungi in China. It offers Flammulina velutipes, and Shinji mushrooms, including white jade and crab-flavored mushrooms; and maitake, velvet, and other edible mushrooms.
Jiangsu Chinagreen Biological Technology Co.,Ltd. Fundamentals Summary
| 300970 fundamental statistics | |
|---|---|
| Market cap | CN¥1.38b |
| Earnings (TTM) | CN¥87.09m |
| Revenue (TTM) | CN¥974.87m |
15.8x
P/E Ratio1.4x
P/S RatioIs 300970 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300970 income statement (TTM) | |
|---|---|
| Revenue | CN¥974.87m |
| Cost of Revenue | CN¥795.23m |
| Gross Profit | CN¥179.64m |
| Other Expenses | CN¥92.55m |
| Earnings | CN¥87.09m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 23, 2024
| Earnings per share (EPS) | 0.74 |
| Gross Margin | 18.43% |
| Net Profit Margin | 8.93% |
| Debt/Equity Ratio | 18.4% |
How did 300970 perform over the long term?
See historical performance and comparison